Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
  Barrierefreiheit    Kontakt MedUni Wien    Intranet    MedUni Wien - Shop    Universitätsbibliothek    Universitätsklinikum AKH Wien  
 
ccc_logo_en.gif
 
AKH Wien
 
 
Hauptnavigation
  • Home
  • Über das CCC
    • Allgemeines
    • Leitung der Organisationseinheit
    • CCC-Office Team
    • Kliniken und Partner
    • Qualitätsmanagement
    • Kontakt
  • PatientInnen
    • Covid-19
    • Allgemeines
    • Cancer School
    • Terminvereinbarung
    • Pflegeambulanz
    • PatientInnenvertretung
    • Links
  • Klinischer Bereich
    • Allgemeines
    • CCC Tumorboards
  • Wissenschaft & Forschung
    • Young CCC
    • CCC-ExpertInnenvideos
    • CCC Forschungscluster
    • CCC Units
    • CCC Platforms
    • Translationale Forschung
    • CCC Best Paper Award
    • CCC-TRIO Symposium
    • Kontakt/Links
  • Lehre
    • CCC Cancer School
    • CCC Cancer Update
    • Vienna International Summer School on Clinical and Experimental Oncology - VSSO
    • Interdisziplinäre onkologische Ausbildung
    • Klinisch-Praktisches Jahr (KPJ)
    • PhD Programme
    • Postgraduelle Fort- und Weiterbildung
    • Information/Contact
 
 
Subnavigation
    Inhaltsbereich


    Zurück zur Übersicht
    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2016 Jul 5. pii: mdw235. doi: 10.1093/annonc/mdw235
    ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
    Van Cutsem E1,  Cervantes A2,  Adam R3,  Sobrero A4,  Van Krieken JH5,  Aderka D6,  Aranda Aguilar E7,  Bardelli A8,  Benson A9,  Bodoky G10,  Ciardiello F11,  D'Hoore A12,  Diaz-Rubio E13,  Douillard JY14,  Ducreux M15,  Falcone A16,  Grothey A17,  Gruenberger T18,  Haustermans K19,  Heinemann V20,  Hoff P21,  Köhne CH22,  Labianca R23,  Laurent-Puig P24,  Ma B25,  Maughan T26,  Muro K27,  Normanno N28,  Österlund P29,  Oyen WJ30,  Papamichael D31,  Pentheroudakis G32,  Pfeiffer P33,  Price TJ34,  Punt C35,  Ricke J36,  Roth A37,  Salazar R38,  Scheithauer W39,  Schmoll HJ40,  Tabernero J41,  Taïeb J42,  Tejpar S43,  Wasan H44,  Yoshino T45,  Zaanan A46,  Arnold D47
    Author information
    1Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium clinicalguidelines@esmo.org.
    2Medical Oncology Department, INCLIVA University of Valencia, Valencia, Spain.
    3Hepato-Biliary Centre, Paul Brousse Hospital, Villejuif, France.
    4Medical Oncology, IRCCS San Martino Hospital, Genova, Italy.
    5Research Institute for Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
    6Division of Oncology, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
    7Medical Oncology Department, University Hospital Reina Sofia, Cordoba, Spain.
    8School of Medicine, University of Turin, Turin, Italy.
    9Division of Hematology/Oncology, Northwestern Medical Group, Chicago, USA.
    10Department of Oncology, St László Hospital, Budapest, Hungary.
    11Division of Medical Oncology, Seconda Università di Napoli, Naples, Italy.
    12Abdominal Surgery, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
    13Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
    14Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), St Herblain.
    15Department of Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
    16Department of Medical Oncology, University of Pisa, Pisa, Italy Division of Medical Oncology, Department of Oncology, University Hospital 'S. Chiara', Istituto Toscano Tumori, Pisa, Italy.
    17Division of Medical Oncology, Mayo Clinic, Rochester, USA.
    18Department of Surgery I, Rudolfstiftung Hospital, Vienna, Austria.
    19Department of Radiation Oncology, University Hospitals Gasthuisberg and KU Leuven, Leuven, Belgium.
    20Comprehensive Cancer Center, University Clinic Munich, Munich, Germany.
    21Instituto do Câncer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil.
    22Northwest German Cancer Center, University Campus Klinikum Oldenburg, Oldenburg, Germany.
    23Cancer Center, Ospedale Giovanni XXIII, Bergamo, Italy.
    24Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
    25Department of Clinical Oncology, Prince of Wales Hospital, State Key Laboratory in Oncology in South China, Chinese University of Hong Kong, Shatin, Hong Kong.
    26CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Oxford, UK.
    27Department of Clinical Oncology and Outpatient Treatment Center, Aichi Cancer Center Hospital, Nagoya, Japan.
    28Cell Biology and Biotherapy Unit, I.N.T. Fondazione G. Pascale, Napoli, Italy.
    29Helsinki University Central Hospital, Comprehensive Cancer Center, Helsinki, Finland Department of Oncology, University of Helsinki, Helsinki, Finland.
    30The Institute of Cancer Research and The Royal Marsden Hospital, London, UK.
    31Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia, Cyprus.
    32Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
    33Department of Oncology, Odense University Hospital, Odense, Denmark.
    34Haematology and Medical Oncology Unit, Queen Elizabeth Hospital, Woodville, Australia.
    35Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
    36Department of Radiology and Nuclear Medicine, University Clinic Magdeburg, Magdeburg, Germany.
    37Digestive Tumors Unit, Geneva University Hospitals (HUG), Geneva, Switzerland.
    38Catalan Institute of Oncology (ICO), Barcelona, Spain.
    39Department of Internal Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
    40Department of Internal Medicine IV, University Clinic Halle, Martin-Luther-University Halle-Wittenberg, Halle, Germany.
    41Medical Oncology Department, Vall d' Hebron University Hospital, Vall d'Hebron Institute of Oncology (V.H.I.O.), Barcelona, Spain.
    42Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
    43Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium.
    44Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
    45Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
    46Digestive Oncology Department, European Hospital Georges Pompidou, Paris, France.
    47Instituto CUF de Oncologia (ICO), Lisbon, Portugal.
    Abstract

    Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.


    © The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

    KEYWORDS: ESMO, clinical practice guidelines, colorectal cancer, consensus

    Publikations ID: 27380959
    Quelle: öffnen
     
    Drucken
     
    ccc_logo_en.gif
    ccc_logo_en.gif
    ccc_logo_en.gif

    Schnellinfo

     
    -- Initiative Krebsforschung / Krebsforschungslauf

    -- Cancer Care
    -- Kliniken und Partner
    -- CCC Cancer School
    -- Young CCC
    -- CCC Tumorboards
    -- CCC Forschungscluster
    -- CCC Units
    -- CCC Platforms
    -- SOPs / Leitlinien
    -- Kontakt
    Zuklappen
     
    Ausklappen
     
     

    Featured

     
     
     
     
     
     
     
     
     
     
     
     
     
    © MedUni Wien |
     Impressum | Nutzungsbedingungen | Kontakt